Roche announces U.S. market availability of Elecsys HE4 assay

theflyonthewall.com

Roche announced the U.S. market availability of the Elecsys HE4 assay, an FDA approved test used in monitoring patients with ovarian cancer. The HE4 test is used as an aid in monitoring the recurrence or progressive disease in patients with epithelial ovarian cancer.

View Comments